Major depressive disorder in Parkinson's disease: A cross-sectional study from Sri Lanka

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Ketharanathan, Tharini ^a   Hanwella, Raveen ^b   Weerasundera, Rajiv ^c   De Silva, Varuni A ^b  

^a North Western Mental Health   (Australia)

^b UNIVERSITY OF COLOMBO   (Sri Lanka)

^c UNIVERSITY OF SRI JAYEWARDENEPURA   (Sri Lanka)

Author keywords

Depression; Parkinson's disease; Prevalence; Sri Lanka

Indexed keywords

AMANTADINE; BROMOCRIPTINE; CLONAZEPAM; LEVODOPA; PROPRANOLOL; ROPINIROLE; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; CAREGIVER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DISEASE DURATION; DSM-IV-TR; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PARKINSON DISEASE; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SEMI STRUCTURED INTERVIEW; SRI LANKA; TERTIARY HEALTH CARE; UNITED KINGDOM; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SRI LANKA;

EID: 84907663105     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0278-8     Document Type: Article

References (32)

1. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol Psychiatry 2003, 54(3):363-375. 10.1016/S0006-3223(03)00530-4, 12893111.
2. Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T. Clinical correlates of depressive symptoms in familial Parkinson's disease. Mov Disord 2008, 23(15):2216-2223. 10.1002/mds.22285, 18785635.
3. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001, 16:507-510. 10.1002/mds.1099, 11391746.
4. Marsh L. Neuropsychiatric aspects of Parkinson's disease. Psychosomatics 2000, 41:15-23. 10.1016/S0033-3182(00)71169-8, 10665264.
5. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992, 149:443-454. 1372794.
6. Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in Parkinson disease-epidemiology, mechanisms and management. Nat Rev Neurol 2012, 11:35-47.
7. Kuopio A, Marttila RJ, Helenius H, Toivonen M, Rinne UK. The quality of life in Parkinson's disease. Mov Disord 2001, 15(2):216-223. 10.1002/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO;2-#.
8. Arun MP, Bharath S, Pal PK, Singh G. Relationship of depression, disability, and quality of life in Parkinson's disease: a hospital-based case-control study. Neurol India 2011, 59:185-189. 10.4103/0028-3886.91395, 21483114.
9. Daniel SE, Lees AJ. Parkinson's disease society brain bank. London: overview and research. J Neural Transm 1993, 39:165-172.
10. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442. 10.1212/WNL.17.5.427, 6067254.
11. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. Third symposium on surgery in Parkinson's disease 1969, 152-157. Livingstone, Edinburgh, Gillingham FJ, Donaldson IML.
12. Diagnostic and statistical manual of mental disorders (4th ed., text rev.) 2000, American Psychiatric Association, Washington, DC.
13. Montgomery SA, Asberg M. A new depression scale, designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389. 10.1192/bjp.134.4.382, 444788.
14. Muller MJ, Szegedi A, Wetzel H, Benkert O. Moderate and severe depression. Gradations for the Montgomery-Asberg depression rating scale. J Affect Disord 2000, 60(2):137-140. 10.1016/S0165-0327(99)00162-7, 10967373.
15. University of Surrey: Social research update. []., http://sru.soc.surrey.ac.uk/SRU9.html
16. Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry 2000, 15(7):644-649. 10.1002/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L, 10918346.
17. Tandberg E, Larsen JP, Aarsland D, Laake K, Cummings JL. Risk factors for depression in Parkinson disease. Arch Neurol 1997, 54:625-630. 10.1001/archneur.1997.00550170097020, 9152120.
18. Rojo A, Aguilar M, Garolera MT, Cubo E, Navas I, Quintana S. Depression in Parkinson's disease: clinical correlates and outcome. Parkinsonism Relat Disord 2003, 10:23-28. 10.1016/S1353-8020(03)00067-1, 14499203.
19. Liu CY, Wang SJ, Fuh JL, Lin CH, Yang YY, Liu HC. The correlation of depression with functional activity in Parkinson's disease. J Neurol 1997, 244:493-498. 10.1007/s004150050131, 9309555.
20. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008, 23:183-189. 10.1002/mds.21803, 17987654.
21. Go CL, Rosales RL, Joya-Tanglao M, Fernández HH. Untreated depressive symptoms among cognitively-intact, community dwelling Filipino patients with Parkinson disease. Int J Neurosci 2011, 121:137-141. 10.3109/00207454.2010.537414, 21126107.
22. Oguru M, Tachibana H, Toda K, Okuda B, Oka N. Apathy and depression in Parkinson disease. J Geriatr Psychiatry Neurol 2010, 23(1):35-41. 10.1177/0891988709351834, 20015839.
23. Yamanishi T, Tachibana H, Oguru M, Matsui K, Toda K, Okuda B, Oka N. Anxiety and depression in patients with Parkinson's disease. Intern Med 2013, 52:539-545. 10.2169/internalmedicine.52.8617, 23448761.
24. Suzuki K, Miyamoto M, Miyamoto T, Okuma Y, Hattori N, Kamei S, Yoshii F, Utsumi H, Iwasaki Y, Iijima M, Hirata K. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease. Parkinsonism Relat Disord 2009, 15(1):15-19. 10.1016/j.parkreldis.2008.02.002, 18359262.
25. Zheng J, Sun S, Qiao X, Liu Y. Depression in patients with Parkinson's disease and the associated features. J Huazhong Univ Sci Technolog Med Sci 2009, 29(6):725-728. 10.1007/s11596-009-0610-6, 20037815.
26. Inoue T, Kitagawa M, Tanaka T, Nakagawa S, Koyama T. Depression and major depressive disorder in patients with Parkinson's disease. Mov Disord 2010, 25(1):44-49. 10.1002/mds.22921, 20014057.
27. Lemke MR, Fuchs G, Gemende I, Herting B, Oehlwein C, Reichmann H, Rieke J, Volkmann J. Depression and Parkinson's disease. J Neurol 2004, 251(Suppl 6):VI/24-VI/27.
28. Hobson DE, Pourcher E, Martin WRW. Ropinirole and pramipexole, the new agonists. Can J Neurol Sci 1999, 26(Suppl 2):S27-S33. 10451757.
29. Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ. Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol 1990, 3:3-9. 10.1177/089198879000300102, 2140682.
30. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord 2012, 142(Suppl):S8-S21. 10.1016/S0165-0327(12)70004-6, 23062861.
31. Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol 2006, 5:355-363. 10.1016/S1474-4422(06)70411-2, 16545752.
32. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 1996, 53:175-179. 10.1001/archneur.1996.00550020087019, 8639068.